← Back to Search

coaching in context for Spinal Cord Injury

N/A
Waitlist Available
Led By MJ Mulcahey, PhD
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline - before coaching and repeated at end of 10 coaching sessions (12 weeks from baseline)
Awards & highlights

Study Summary

This pilot study has two aims. The first aim is to establish the feasibility of coaching for caregivers of youth with spinal cord injury, and the second aim is to establish methodological procedures for a future multi-center study on the effectiveness of coaching as an intervention for caregivers of youth with spinal cord injury.

Eligible Conditions
  • Spinal Cord Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline - before coaching and repeated at end of 10 coaching sessions (12 weeks from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - before coaching and repeated at end of 10 coaching sessions (12 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Canadian Occupational Performance Measure (COPM)

Trial Design

1Treatment groups
Experimental Treatment
Group I: coaching in contextExperimental Treatment1 Intervention
10, 1 hour sessions of face to face strength based coaching sessions provided face to face or over the phone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
strength based coaching
2018
N/A
~10

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
444 Previous Clinical Trials
145,615 Total Patients Enrolled
MJ Mulcahey, PhDPrincipal InvestigatorThomas Jefferson University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025